• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软组织巨细胞瘤在基因上与其骨组织对应物不同。

Giant cell tumor of soft tissue is genetically distinct from its bone counterpart.

作者信息

Lee Jen-Chieh, Liang Cher-Wei, Fletcher Christopher Dm

机构信息

Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Mod Pathol. 2017 May;30(5):728-733. doi: 10.1038/modpathol.2016.236. Epub 2017 Jan 13.

DOI:10.1038/modpathol.2016.236
PMID:28084336
Abstract

Giant cell tumors of bone are locally aggressive bone neoplasms with a predilection for young adults. Histologically, they are composed of histiocytoid to spindled mononuclear cells, admixed with numerous large osteoclastic giant cells. Giant cell tumors of soft tissue are rare tumors that bear striking histological resemblance to giant cell tumors of bone and might be regarded as a soft tissue analog thereof. Point mutations of the H3F3A gene (coding for a histone H3.3 protein) at the Gly34 codon, mostly G34W resulting from a GGG>TGG nucleotide change, have recently been identified in a vast majority of giant cell tumors of bone. To delineate the possible pathogenic linkage between both tumor types, we analyzed the H3F3A genotypes in a series of 15 giant cell tumors of soft tissue by Sanger sequencing and found no mutation in any case. We then sequenced cognate histone H3 genes with an identical nucleotide sequence ('GGG') at the codon Gly34, including the H3F3B, H3F3C, HIST2H3A, HIST2H3C, and HIST2H3D genes, and no somatic mutation was detected. These results reveal that giant cell tumors of soft tissue are probably genetically distinct from their bone counterparts and suggest that they might be pathogenically unrelated. Given the prominence of non-neoplastic cells in these tumors and the limitations of the current study, however, analyses using more sensitive techniques might be required to solve the issue.

摘要

骨巨细胞瘤是具有局部侵袭性的骨肿瘤,好发于年轻人。在组织学上,它们由组织细胞样至梭形单核细胞组成,并混有大量大的破骨细胞样巨细胞。软组织巨细胞瘤是罕见肿瘤,在组织学上与骨巨细胞瘤有显著相似之处,可被视为骨巨细胞瘤的软组织类似物。最近在绝大多数骨巨细胞瘤中发现了H3F3A基因(编码组蛋白H3.3蛋白)第34密码子甘氨酸处的点突变,大多是由GGG>TGG核苷酸变化导致的G34W突变。为了阐明这两种肿瘤类型之间可能的致病联系,我们通过桑格测序分析了15例软组织巨细胞瘤系列中的H3F3A基因型,结果在任何病例中均未发现突变。然后我们对密码子34处具有相同核苷酸序列(“GGG”)的同源组蛋白H3基因进行测序,包括H3F3B、H3F3C、HIST2H3A、HIST2H3C和HIST2H3D基因,未检测到体细胞突变。这些结果表明,软组织巨细胞瘤在遗传上可能与其骨对应物不同,并提示它们在致病方面可能无关。然而,鉴于这些肿瘤中非肿瘤细胞的突出性以及本研究的局限性,可能需要使用更敏感的技术进行分析来解决这一问题。

相似文献

1
Giant cell tumor of soft tissue is genetically distinct from its bone counterpart.软组织巨细胞瘤在基因上与其骨组织对应物不同。
Mod Pathol. 2017 May;30(5):728-733. doi: 10.1038/modpathol.2016.236. Epub 2017 Jan 13.
2
Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.软组织巨细胞瘤与其骨 counterpart 之间的表型和分子差异。
Histopathology. 2017 Sep;71(3):453-460. doi: 10.1111/his.13249. Epub 2017 Jun 29.
3
H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.在 366 例骨巨细胞瘤和其他骨肿瘤中进行 H3F3A G34 突变 DNA 测序和 G34W 免疫组织化学分析。
Histol Histopathol. 2021 Jan;36(1):61-68. doi: 10.14670/HH-18-264. Epub 2020 Sep 4.
4
H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.免疫组织化学使用针对组蛋白 H3.3 变体 G34W 突变位点的单克隆抗体检测骨巨细胞瘤中的 H3F3A 突变。
Histopathology. 2017 Jul;71(1):125-133. doi: 10.1111/his.13190. Epub 2017 Apr 10.
5
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.H3F3A和H3F3B的突变分析作为骨巨细胞瘤和软骨母细胞瘤的诊断工具
Am J Surg Pathol. 2015 Nov;39(11):1576-83. doi: 10.1097/PAS.0000000000000512.
6
Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.在恶性骨巨细胞瘤的一个亚组中不存在 H3F3A 突变。
Mod Pathol. 2019 Dec;32(12):1751-1761. doi: 10.1038/s41379-019-0318-5. Epub 2019 Jul 8.
7
Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.组蛋白 H3.3 G34W、G34R 和 G34V 突变体特异性抗体在骨巨细胞瘤中的诊断效用。
Hum Pathol. 2018 Mar;73:41-50. doi: 10.1016/j.humpath.2017.11.020. Epub 2017 Dec 12.
8
Expression of H3.3 G34W Distinguishes Giant Cell Tumor of Bone From Its Major Giant Cell-containing Bone and Soft Tissue Mimics, in Particular Aneurysmal Bone Cyst and Giant Cell Tumor of Soft Tissue.H3.3 G34W的表达可将骨巨细胞瘤与其主要的含巨细胞的骨和软组织模仿物区分开来,尤其是骨动脉瘤样囊肿和软组织巨细胞瘤。
Appl Immunohistochem Mol Morphol. 2020 May/Jun;28(5):e47-e48. doi: 10.1097/PAI.0000000000000636.
9
Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.免疫组织化学染色检测 H3G34W 和 H3K36M 对 FNA 和核心针活检中的骨巨细胞瘤和软骨母细胞瘤具有高度特异性。
Cancer Cytopathol. 2018 Aug;126(8):552-566. doi: 10.1002/cncy.22000. Epub 2018 May 14.
10
Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.骨巨细胞瘤和富含巨细胞的骨肉瘤中的组蛋白3.3突变。
Hum Pathol. 2017 Oct;68:128-135. doi: 10.1016/j.humpath.2017.08.033. Epub 2017 Sep 9.

引用本文的文献

1
Intramuscular Soft Tissue Giant Cell Tumor of the Forearm: A Case Report.前臂肌内软组织巨细胞瘤:一例报告
Clin Case Rep. 2025 Mar 28;13(4):e70371. doi: 10.1002/ccr3.70371. eCollection 2025 Apr.
2
Giant Cell Tumor of Soft Tissue: An Updated Review.软组织巨细胞瘤:最新综述
J Clin Med. 2024 May 13;13(10):2870. doi: 10.3390/jcm13102870.
3
Keratin-Positive Giant Cell-Rich Tumor: A Review and Update.富含角蛋白阳性巨细胞的肿瘤:综述与更新

本文引用的文献

1
Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients.18岁及以下骨巨细胞瘤(GCT)患者的组织学谱:63例患者的研究
Am J Surg Pathol. 2016 Dec;40(12):1702-1712. doi: 10.1097/PAS.0000000000000715.
2
Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.FN1-FGFR1 和新型 FN1-FGF1 融合基因在一系列大型磷酸尿素质瘤中的特征。
Mod Pathol. 2016 Nov;29(11):1335-1346. doi: 10.1038/modpathol.2016.137. Epub 2016 Jul 22.
3
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape.
Cancers (Basel). 2024 May 20;16(10):1940. doi: 10.3390/cancers16101940.
4
Giant cell tumor of soft tissue involving thyroid gland: a case report and review of the literature.软组织巨细胞瘤累及甲状腺:病例报告及文献复习。
J Med Case Rep. 2024 Mar 22;18(1):123. doi: 10.1186/s13256-024-04450-1.
5
Giant cell tumor of paralaryngeal soft tissues, extending to the laryngeal cartilage.喉旁软组织巨细胞瘤,累及喉软骨。
Radiol Case Rep. 2024 Jan 27;19(4):1575-1578. doi: 10.1016/j.radcr.2024.01.024. eCollection 2024 Apr.
6
Case report of a giant cell tumor of the carotid sheath.颈动脉鞘巨细胞瘤病例报告。
Radiol Case Rep. 2023 May 23;18(8):2558-2561. doi: 10.1016/j.radcr.2023.04.043. eCollection 2023 Aug.
7
Case Report: Giant Cell Tumor of Tendon Sheath After Breast Augmentation.病例报告:隆胸术后腱鞘巨细胞瘤
Front Oncol. 2022 Jun 22;12:878635. doi: 10.3389/fonc.2022.878635. eCollection 2022.
8
Molecular testing of soft tissue tumors.软组织肿瘤的分子检测。
Diagn Cytopathol. 2023 Jan;51(1):12-25. doi: 10.1002/dc.25013. Epub 2022 Jul 9.
9
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.地诺单抗治疗骨巨细胞瘤(GCTB)后骨转换标志物(BTM)的变化:一项II期试验相关研究
Cancers (Basel). 2022 Jun 10;14(12):2863. doi: 10.3390/cancers14122863.
10
Malignant giant cell tumor in the left upper arm soft tissue of an adolescent: A case report.青少年左上臂软组织恶性巨细胞瘤1例报告
World J Clin Cases. 2021 May 26;9(15):3704-3710. doi: 10.12998/wjcc.v9.i15.3704.
超越转录因子:致癌信号如何重塑表观遗传格局。
Nat Rev Cancer. 2016 Jun;16(6):359-72. doi: 10.1038/nrc.2016.41.
4
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.H3F3A和H3F3B的突变分析作为骨巨细胞瘤和软骨母细胞瘤的诊断工具
Am J Surg Pathol. 2015 Nov;39(11):1576-83. doi: 10.1097/PAS.0000000000000512.
5
Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.地诺单抗治疗的骨巨细胞瘤:一系列病例的形态学、免疫组织化学及分子分析
J Clin Pathol. 2016 Mar;69(3):240-7. doi: 10.1136/jclinpath-2015-203248. Epub 2015 Sep 3.
6
The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.骨巨细胞瘤中高度常见的H3F3A突变在颌骨散发性中央巨细胞病变中并不存在。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Nov;118(5):583-5. doi: 10.1016/j.oooo.2014.07.011. Epub 2014 Aug 1.
7
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas.K27M 突变型小儿高级别胶质瘤中 H3K27me3 减少和 DNA 低甲基化是基因表达的主要驱动因素。
Cancer Cell. 2013 Nov 11;24(5):660-72. doi: 10.1016/j.ccr.2013.10.006. Epub 2013 Oct 31.
8
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.H3F3A 和 H3F3B 的驱动突变可明确区分软骨母细胞瘤和骨巨细胞瘤。
Nat Genet. 2013 Dec;45(12):1479-82. doi: 10.1038/ng.2814. Epub 2013 Oct 27.
9
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.组蛋白 H3.3K27M 突变在小儿神经胶质瘤中重塑 H3K27 甲基化和基因表达。
Genes Dev. 2013 May 1;27(9):985-90. doi: 10.1101/gad.217778.113. Epub 2013 Apr 19.
10
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.功能获得性 H3 突变抑制 PRC2 活性,该突变存在于小儿脑胶质瘤中。
Science. 2013 May 17;340(6134):857-61. doi: 10.1126/science.1232245. Epub 2013 Mar 28.